NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
12/18/2023
Back to search
Official data from USPTO
CTI CLINICAL TRIAL & CONSULTING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
12/18/2023
Trademark type
Combined
Nice classes
42
Filing date
06/07/2017
Registration date
06/05/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/18/2023
Last transaction
12/18/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
2013-10-00
First use in commerce
2013-10-00
Drawing code
3
Owner type
03
Owner location
Covington, KY
Examiner
GOLDEN, LAURA
Law office
L30
Current location
TMEG LAW OFFICE 103
Mark description
The mark consists of a solid circle enclosing a representation of an open infinity symbol to the left of the letters, "CTI", and the words, "CLINICAL TRIAL & CONSULTING".
Holders and representatives
Holders
C. S. (pessoa física)
Representatives
J. Michael Hurst KEATING MUETHING & KLEKAMP PLL
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
medical and scientific researchconducting clinical trials for others
Publications
History of USPTO decisions and trademark events.
31 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
12/18/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/18/2023
E815
TEAS SECTION 8 & 15 RECEIVED
06/22/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/05/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
06/05/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/20/2018
PUBO
PUBLISHED FOR OPPOSITION
03/20/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/28/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/15/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/13/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/13/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/13/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/07/2018
GNRT
NON-FINAL ACTION E-MAILED
02/07/2018
CNRT
NON-FINAL ACTION WRITTEN
02/07/2018
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/08/2018
PBSR
WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
12/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/28/2017
DOCK
ASSIGNED TO EXAMINER
10/20/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/17/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2017
ALIE
ASSIGNED TO LIE
10/12/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/29/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/07/2017
GNRT
NON-FINAL ACTION E-MAILED
09/07/2017
CNRT
NON-FINAL ACTION WRITTEN
09/07/2017
DOCK
ASSIGNED TO EXAMINER
09/07/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/15/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/14/2017
NWAP
NEW APPLICATION ENTERED
06/10/2017
Continuous trademark protection
Get notified about every new filing that threatens CTI CLINICAL TRIAL & CONSULTING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.